Journals / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 1

Risk Factors of Mortality from Acinetobacter Baumannii Infection in Intensive Care Units

Pages
56–60
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found that previous antibiotic use, the need for mechanical aspiration, advanced age, the use ofa nasogastric catheter and isolation of AB pathogen from tracheal aspirate were the risk factors for mortality from ABinfection.Conclusion: Given the high prevalence of this pathogen especially in intensive care units and its resistance againstmultidrug antibiotics, we believe that further studies should be continuously conducted studies on this pathogen willprovide contribution to the development of new treatment strategies and antibiotics

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The incidence of Acinetobacter baumannii pathogen is high especially among patients hospitalized inintensive care units.
📊
Key Findings & Data:The objective of this study was to investigate risk factors affecting mortality in patients hospitalizedin the intensive care units due to various reasons in whom AB infection was detected.Methods: A total of 28 patients hospitalized in the intensive care units of our hospital who have AB infection detectedwith culture tests were included in the study.
💡
Conclusion & Impact:We found that previous antibiotic use, the need for mechanical aspiration, advanced age, the use ofa nasogastric catheter and isolation of AB pathogen from tracheal aspirate were the risk factors for mortality from ABinfection.Conclusion: Given the high prevalence of this pathogen especially in intensive care units and its resistance againstmultidrug antibiotics, we believe that further studies should be continuously conducted studies on this pathogen willprovide contribution to the development of new treatment strategies and antibiotics
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The incidence of Acinetobacter baumannii pathogen is high especially among patients hospitalized inintensive care units. The objective of this study was to investigate risk factors affecting mortality in patients hospitalizedin the intensive care units due to various reasons in whom AB infection was detected.Methods: A total of 28 patients hospitalized in the intensive care units of our hospital who have AB infection detectedwith culture tests were included in the study. Patients’ demographic data such as age and gender, admission diagnosis,duration of hospitalization, and infection types and comorbidities were obtained from the hospital records.Results: Of all patients, 39.3% were female and 60.7% were male. The mean duration of hospitalization was found as57.9±48.0 days. We found that previous antibiotic use, the need for mechanical aspiration, advanced age, the use ofa nasogastric catheter and isolation of AB pathogen from tracheal aspirate were the risk factors for mortality from ABinfection.Conclusion: Given the high prevalence of this pathogen especially in intensive care units and its resistance againstmultidrug antibiotics, we believe that further studies should be continuously conducted studies on this pathogen willprovide contribution to the development of new treatment strategies and antibiotics

🔖

Cite This Article

TASDOĞAN, A. M. (2022). Risk Factors of Mortality from Acinetobacter Baumannii Infection in Intensive Care Units. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 1, 56–60. https://ajindex.com/articles/508693

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 2008;28:15– 25
  2. Cerqueira GM, Peleg AY. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life 2011;63:105560; PMID:21989983
  3. Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect 2009;73:355–63
  4. Taskin G, Oztürk K, Turker T, Nesrin O, Mustafa C, Ozer S et al. Assessment of mortality risk factors for critically ill patients with acinetobacter baumannii bacteremia with a new perspective; Acta Medica Mediterranea 2016;32:1892–7
  5. Vitkauskiene A, Dambrauskiene A, Cerniauskiene K, Rimdeika R, Sakalauskas R. Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection. Scand J Infect Dis 2013;45:213–8. 60 Tasdogan, Acinetobacter Baumannii Infection / doi: 10.14744/ejmi.2019.24282 6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–40
  6. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003;29:471–5
  7. Tseng YC, Wang JT, Wu FL, Chen YC, Chie WC, Chang SC. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2007;59:181–90
  8. Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multidrug resistance. Eur J Clin Microbiol Infect Dis 2008;27:607–12
  9. Sahin AR, Dogruer D, Nazik S, Aktemur A, Oksuz H, Aral M et al. Increasing Antimicrobial Resistance Problem of Nosocomial Pathogens: Acinetobacter baumannii, Online Türk Sağlık Bilimleri Dergisi 2019;4:2:156–69
  10. Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Critical Care 2007;11:134
  11. Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study
  12. Poutanen SM, Louie M, Simor AE. Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults. Eur J Clin Microbiol Infect Dis 1997;16:737–40
  13. Se Yoon Park, Jin Woo Choo, Soon Ha Kwon, Shi Nae Yu, Eun Jung Lee, Tae Hyong Kim et al. Risk Factors for Mortality in Pati